Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding

The non-vitamin K antagonist oral anticoagulants (NOACs) have considerably changed clinical practice and are increasingly being used as an alternative to vitamin K antagonists (VKAs) for 3 main reasons: 1) an improved benefit-risk ratio (in particular lower rates of intracranial bleeding), 2) a more...

Descripción completa

Detalles Bibliográficos
Autores principales: Gremmel, Thomas, Niessner, Alexander, Domanovits, Hans, Frossard, Martin, Sengölge, Gürkan, Steinlechner, Barbara, Sycha, Thomas, Wolzt, Michael, Pabinger, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2018
Materias:
Consensus Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290726/
https://www.ncbi.nlm.nih.gov/pubmed/30128955
http://dx.doi.org/10.1007/s00508-018-1381-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290726/
https://www.ncbi.nlm.nih.gov/pubmed/30128955
http://dx.doi.org/10.1007/s00508-018-1381-5

Ejemplares similares